WHO ICTRP trial
A study to find out the effect of crushing and administering the…
CTRI/2018/01/011458 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2018/01/011458 |
|---|---|
| Public title | A study to find out the effect of crushing and administering the tablets/capsules on the drug levels in the blood |
| Scientific title | A comparative study to evaluate the effect of administering whole versus crushed solid oral dosage forms on PK of drugs in cancer patients |
| Primary sponsor | Tata Memorial Hospital |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C039- Malignant neoplasm of gum, unspecified Health Condition 3: C138- Malignant neoplasm of overlappingsites of hypopharynx Health Condition 4: C148… |
| Interventions | Intervention1: Pantoprazole, Ranitidine, Aprepitant, Capecitabine, Methotrexate. Erlotinib, Celecoxib, Tramadol, Alprazolam, Fluconazole: The drugs will be administered as a part of routine management. No intervention for the purpose of the… |
| Registration date | Jan 19, 2018 |
| Target size | 510 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: